The pace of innovation in oncology is accelerating — but turning breakthroughs into real-world patient impact requires significant commercial investment, often starting years before approval. To help busy clinicians keep pace with this rapid evolution and ensure patients quickly get the therapies they need, commercial teams must be equipped with the most accurate, insightful data available. Traditional data sources reflect historical treatment patterns, not the evolving clinical factors shaping care decisions today. Real-world data (RWD) coming directly from EHR systems offers the depth and timeliness that conventional sources can't match — enabling biopharma commercial teams to anticipate barriers to optimal care and identify unmet patient needs before they appear in lagging metrics. In this webinar, you’ll learn:How RWD can enrich claims and primary market research data for a more complete view of the oncology treatment landscape on where and why unmet clinical need existsHow AI-powered approaches enable commercial teams to understand the ‘why’ behind clinical decision-making at scaleHow biopharma commercial teams are using EHR-sourced data-driven insights to better understand how therapies are reaching the patients most likely to benefit